Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
6.15
+0.26 (4.41%)
At close: Mar 9, 2026, 4:00 PM EDT
5.85
-0.30 (-4.88%)
After-hours: Mar 9, 2026, 7:47 PM EDT
Atea Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -158.35 | -168.39 | -135.96 | -115.91 | 121.19 | |
| Depreciation & Amortization | 0.42 | 0.42 | 0.42 | 0.26 | 0.03 | |
| Loss (Gain) From Sale of Investments | -4.94 | -11.82 | -15.45 | -5.47 | - | |
| Stock-Based Compensation | 20.72 | 51.77 | 49.43 | 46.72 | 39.62 | |
| Other Operating Activities | -6.36 | - | - | - | - | |
| Change in Accounts Payable | 8.49 | 0.21 | 1.7 | -1.98 | 10.29 | |
| Change in Unearned Revenue | - | - | - | - | -301.37 | |
| Change in Other Net Operating Assets | 8 | -7.68 | 14.46 | -44.6 | 43.23 | |
| Operating Cash Flow | -132.03 | -135.5 | -85.4 | -120.98 | -87.01 | |
| Capital Expenditures | - | - | - | -1.94 | -0 | |
| Investment in Securities | 188.79 | 56.11 | 40.3 | -453.47 | - | |
| Investing Cash Flow | 188.79 | 56.11 | 40.3 | -455.41 | -0 | |
| Issuance of Common Stock | 0.26 | 0.27 | 0.26 | 0.37 | 1.47 | |
| Repurchase of Common Stock | -26 | - | - | - | - | |
| Financing Cash Flow | -25.75 | 0.27 | 0.26 | 0.37 | 1.47 | |
| Net Cash Flow | 31.02 | -79.13 | -44.84 | -576.02 | -85.54 | |
| Free Cash Flow | -132.03 | -135.5 | -85.4 | -122.93 | -87.01 | |
| Free Cash Flow Margin | - | - | - | - | -24.76% | |
| Free Cash Flow Per Share | -1.62 | -1.61 | -1.02 | -1.48 | -0.99 | |
| Levered Free Cash Flow | -71.38 | -39.55 | -9.76 | -69.52 | -127.65 | |
| Unlevered Free Cash Flow | -71.38 | -39.55 | -9.76 | -69.52 | -127.65 | |
| Change in Working Capital | 16.48 | -7.48 | 16.16 | -46.59 | -247.85 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.